These benefits, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the concept of targeting ACKR3 as a singular way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associated disorders. Strengthen more healthy immune function: https://barbarao061fsh8.wikijm.com/user